Literature DB >> 1902099

A geranylgeranyltransferase for rhoA p21 distinct from the farnesyltransferase for ras p21S.

Y Yoshida1, M Kawata, M Katayama, H Horiuchi, Y Kita, Y Takai.   

Abstract

We have clarified that rhoA p21 purified from bovine aortic smooth muscle is geranylgeranylated at the cysteine residue in the C-terminal CAAX motif (A is an aliphatic amino acid and X is any amino acid). In this paper, a geranylgeranyltransferase for rhoA p21 (rhoA p21 GGT) was partially purified from bovine brain cytosol. This enzyme transferred a geranylgeranyl moiety from geranylgeranyl pyrophosphate to rhoA p21 having the CAAX motif (rhoA p21-CAAX) but not to rhoA p21 lacking the AAX portion. rhoA p21 GGT was separated from the previously reported farnesyltransferase for ras p21s (ras p21 FT) by column chromatographies and did not geranylgeranylate or farnesylate c-Ha-ras p21-CAAX. ras p21 FT did not geranylgeranylate or farnesylate rhoA p21-CAAX. These results indicate that rhoA p21 GGT distinct from ras p21 FT is present in bovine brain cytosol.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1902099     DOI: 10.1016/0006-291x(91)91625-m

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  14 in total

1.  Geranylgeranyltransferase I inhibitors target RalB to inhibit anchorage-dependent growth and induce apoptosis and RalA to inhibit anchorage-independent growth.

Authors:  Samuel C Falsetti; De-an Wang; Hairuo Peng; Dora Carrico; Adrienne D Cox; Channing J Der; Andrew D Hamilton; Saïd M Sebti
Journal:  Mol Cell Biol       Date:  2007-09-17       Impact factor: 4.272

2.  Involvement of rho p21 and its inhibitory GDP/GTP exchange protein (rho GDI) in cell motility.

Authors:  K Takaishi; A Kikuchi; S Kuroda; K Kotani; T Sasaki; Y Takai
Journal:  Mol Cell Biol       Date:  1993-01       Impact factor: 4.272

3.  Genetic evidence for in vivo cross-specificity of the CaaX-box protein prenyltransferases farnesyltransferase and geranylgeranyltransferase-I in Saccharomyces cerevisiae.

Authors:  C E Trueblood; Y Ohya; J Rine
Journal:  Mol Cell Biol       Date:  1993-07       Impact factor: 4.272

4.  Posttranslational modification of Ha-ras p21 by farnesyl versus geranylgeranyl isoprenoids is determined by the COOH-terminal amino acid.

Authors:  B T Kinsella; R A Erdman; W A Maltese
Journal:  Proc Natl Acad Sci U S A       Date:  1991-10-15       Impact factor: 11.205

5.  C terminus of the small GTP-binding protein smg p25A contains two geranylgeranylated cysteine residues and a methyl ester.

Authors:  C C Farnsworth; M Kawata; Y Yoshida; Y Takai; M H Gelb; J A Glomset
Journal:  Proc Natl Acad Sci U S A       Date:  1991-07-15       Impact factor: 11.205

6.  Enzymatic modification of proteins with a geranylgeranyl isoprenoid.

Authors:  P J Casey; J A Thissen; J F Moomaw
Journal:  Proc Natl Acad Sci U S A       Date:  1991-10-01       Impact factor: 11.205

7.  Atorvastatin suppresses interferon-gamma -induced neopterin formation and tryptophan degradation in human peripheral blood mononuclear cells and in monocytic cell lines.

Authors:  G Neurauter; B Wirleitner; A Laich; H Schennach; G Weiss; D Fuchs
Journal:  Clin Exp Immunol       Date:  2003-02       Impact factor: 4.330

8.  Regulation of intracellular actin polymerization by prenylated cellular proteins.

Authors:  R G Fenton; H F Kung; D L Longo; M R Smith
Journal:  J Cell Biol       Date:  1992-04       Impact factor: 10.539

9.  Regulation of cytoplasmic division of Xenopus embryo by rho p21 and its inhibitory GDP/GTP exchange protein (rho GDI).

Authors:  K Kishi; T Sasaki; S Kuroda; T Itoh; Y Takai
Journal:  J Cell Biol       Date:  1993-03       Impact factor: 10.539

10.  Mevalonate Biosynthesis Intermediates Are Key Regulators of Innate Immunity in Bovine Endometritis.

Authors:  Gareth D Healey; Christine Collier; Sholeem Griffin; Hans-Joachim Schuberth; Olivier Sandra; David G Smith; Suman Mahan; Isabelle Dieuzy-Labaye; I Martin Sheldon
Journal:  J Immunol       Date:  2015-12-16       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.